Evidence map›Paper›PMID 28630345›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Synthesis of asymmetrical multiantennary human milk oligosaccharides.

Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 165 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Chemoenzymatic Synthesis of Tri-antennary N-Glycans Terminating in Sialyl-LewisChemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Anthony R PruddenComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Lin LiuComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Chantelle J CapicciottiComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Margreet A WolfertComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Shuo WangComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Zhongwei GaoComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Lu MengComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Kelley W MoremenComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602.
Geert-Jan BoonsComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602; g.j.p.h.boons@uu.nl.
University of Georgia · USUtrecht University · NL

Funding

Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D · 2011 to 2017
$18.0M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI LIVE, DAVID H · 2012 to 2019
$14.5M
Recombinant Production of Glycosylation Enzymes for Biochem/Structural StudiesP01GM107012 · NIGMS · UNIVERSITY OF GEORGIA · PI PRESTEGARD, JAMES H. · 2013 to 2017
$7.5M
Novel chemoenzymatic approaches for the synthesis of complex glycansR01GM090269 · NIGMS · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN · 2009 to 2016
$1.8M
Electronics Consoles for Biomolecular NMRS10RR027097 · NCRR · UNIVERSITY OF GEORGIA · PI URBAUER, JEFFREY L · 2011 to 2011
$364k
Aberrant N-Glycan Standards for Mass Spectrometry and Microarray AnalysisF31CA180478 · NCI · UNIVERSITY OF GEORGIA · PI PRUDDEN, ANTHONY · 2013 to 2016
$89k
NCI NIH HHS F31 CA180478NCRR NIH HHS S10 RR027097NHLBI NIH HHS P01 HL107150NIGMS NIH HHS P01 GM107012NIGMS NIH HHS P41 GM103390NIGMS NIH HHS R01 GM090269
6 · The paper itself

Abstract

Despite mammalian glycans typically having highly complex asymmetrical multiantennary architectures, chemical and chemoenzymatic synthesis has almost exclusively focused on the preparation of simpler symmetrical structures. This deficiency hampers investigations into the biology of glycan-binding proteins, which in turn complicates the biomedical use of this class of biomolecules. Herein, we describe an enzymatic strategy, using a limited number of human glycosyltransferases, to access a collection of 60 asymmetric, multiantennary human milk oligosaccharides (HMOs), which were used to develop a glycan microarray. Probing the array with several glycan-binding proteins uncovered that not only terminal glycoepitopes but also complex architectures of glycans can influence binding selectivity in unanticipated manners. N- and O-linked glycans express structural elements of HMOs, and thus, the reported synthetic principles will find broad applicability.

Indexed as

FemaleGlycosyltransferasesHumansMicroarray AnalysisMilk, HumanOligosaccharidesGlycosyltransferasesOligosaccharideschemoenzymatic synthesisglycosyltransferaseshuman milk oligosaccharidesprotein–glycan interactions

Identifiers

PMID28630345
PMCPMC5502611
OpenAlexW2658781598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.